Dr. Boulos Toursarkissian, MD

Dr. Toursarkissian practices at Renal Associates, P.A. in San Antonio, Texas.

Dr. Toursarkissian's NPI, 1073529665, was assigned on August 1, 2006. Dr. Toursarkissian graduated from University Of Kentucky College Of Medicine in 1989. Dr. Toursarkissian's Texas license number on file is K4591.

Dr. Toursarkissian's primary practice is Renal Associates, P.A., at 301 N Frio St, San Antonio, TX 78207 in Bexar County. The practice phone is (210) 614-1231.

Dr. Toursarkissian's primary practice is Renal Associates, P.A. in San Antonio, Texas. Dr. Toursarkissian is also affiliated with Methodist Hospital. The medical group on file is Surgical Oncology Associates of South Texas. Dmand AI also links Dr. Toursarkissian to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Toursarkissian practices, 6 sites in all. Vendor and product names are available with a free account.

Vascular surgery is Dr. Toursarkissian's primary specialty in the NPI Registry, under taxonomy code 2086S0129X. Dr. Toursarkissian is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Toursarkissian's licenses on file in 5 states: Texas, California, Kentucky, Louisiana and Missouri.

Dmand AI lists amputation, blood vessel access for dialysis, carotid revascularization, chronic skin ulcer, heart device and aorta surgery, leg revascularization, lymphedema and peripheral vascular disease among the conditions Dr. Toursarkissian treats.

CMS data shows 1,771 Medicare services from Dr. Toursarkissian across 28 procedure codes in 2024, for 781 Medicare patients. Medicare paid $185,247 for them.

CMS counts 781 Medicare patients who saw Dr. Toursarkissian in 2024. The largest group is 75 to 84, with 306 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 3.45, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Toursarkissian's median patient age at 71, with 49% women.

In 2024, Dr. Toursarkissian wrote 881 Medicare Part D claims for 396 patients. 79% of them were for generic drugs. CMS names the drug for 793 of them, across 12 drugs with 11 or more claims each, at $178,321 in total drug cost. In 2023, CMS named 801 claims across 13 drugs.

Dr. Toursarkissian accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 22 procedures of leg revascularization (restoring blood flow) by Dr. Toursarkissian, more than 82% of the clinicians it reports for that procedure.

Dmand AI links 57 papers to Dr. Toursarkissian, published from 2002 to 2013. 2012 was the busiest year, with 3. The most frequent topics are Stents, Femoral Artery and Angioplasty, Balloon. Dr. Toursarkissian has published most often in Ann Vasc Surg. Dr. Toursarkissian's most frequent co-authors are Paula K. Shireman, MD, Mellick T. Sykes, MD and Ryan T. Hagino, MD.

Dmand AI links Dr. Toursarkissian to 1 clinical trial. Conditions studied include Chronic Limb-Threatening Ischemia and Peripheral Arterial Disease.

CMS Open Payments shows 270 general payments to Dr. Toursarkissian from 34 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 86% of the total. Medtronic Vascular, Inc. paid the most, $2,062.

Dmand AI lists 2 awards for Dr. Toursarkissian, most recently Top Doctors:SE Texas in 2013.

Dr. Toursarkissian graduated from University Of Kentucky College Of Medicine in 1989. Dr. Toursarkissian is a member of ACS and SVS.

Dr. Toursarkissian is in network with 18 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.